Market Research Blog

A number of infectious diseases and the increasing number of resistant strains of microorganisms lead to the development of microbial detection kits. However these traditional methods of culturing and then identification is time consuming. Automated microbial detection systems is one solution for this problem. Using these systems the detection process of microorganisms can be done within a few minutes of culturing and the results could be available within a couple of hours. Automated microbial detection systems are automated tools used for the detection of key contaminant microorganisms. These methods allow for preventive controls and faster testing. The results could be obtained within a few hours using the automated microbial detection systems, when compared to the traditional culturing methods.A number of large and small players provide automated microbial detection systems. Some of them include Thermo Fisher Scientific, Lonza, Pall Corporation, MediRay, BioMeriux and MIDI Inc.

Market Dynamics of Automated Microbial Detection Systems Market

A number of factors drive the growth of the automated microbial detection systems market. Some of these include the increase in incidence of infectious diseases that are coupled with epidemic and pandemic events that occur every year. Increasing food safety concerns is another factor that drives the growth of the automated microbial detection system market. Technology advancements and government initiatives to aid the development of the market further. However, high cost of automated microbial detection systems and complex regulatory framework slightly hinder the growth of the automated microbial detection systems market.

Genotypic Methods are Popularizing

When genotypic methods are applied for the identification of microorganisms it results in specie-specific fingerprints. The genotypic methods of automated microbial detection systems are fast and reliable. New genotypic methods include the use of microchips coated with an array of oligonucleotides that allows rapid identification, by the determination of patterns or sequences that are specific to an organism. DNA sequencing and biochemical sequencing coupled with fluorescent analysis of the product is also being developed for automation.

Automated Microbial Detection Systems Market by Technology

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6955

 

Regional Market Outlook

Although North America will continue to hold the largest share in the automated microbial detection systems market, Asia-Pacific is expected to grow with the largest CAGR.  The continued focus of the major player towards emerging and Asian countries as well as due to the support of the government in these region leads to development of the automated microbial detection systems market in the region.

Competition Outlook

Automated Microbial Detection Systems are expensive devices. Thus the Automated Microbial Detection System Market is dominated by large players like Thermo Fisher Scientific, Becton Dickinson, Merck Millipore and Lonza. The other small players include Biomerieux, MIDI Inc and MediRay.

Small-Scale Manufacturers/Providers	Medium-Scale Manufacturers/Providers	Large-Scale Manufacturers/Providers
MediRay Micro Identification Technologies MIDI, Inc.	Trivitron Healthcare Biomerieux	Thermo Fisher Scientific VWR (Avantor) Becton Dickinson Charles River Merck Millipore Lonza Pall Corporation

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies.

Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6955

Key data points covered in report

The report covers exhaustive analysis on:

• Automated Microbial Detection Systems Market by technology, end user and region
• Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by technology, end use segments and country
• Automated Microbial Detection Systems Market Dynamics & Opportunity Assessment
• Historical Actual Market Size, 2013 – 2017
• Automated Microbial Detection Systems Market Size & Forecast 2018-2028
• Automated Microbial Detection Systems Market Trends/Issues/Challenges
• Competition & Companies involved

Market Segmentation 

By Technology

• Phenotypic Methods
• Genotypic Methods

By End user

• Pharmaceutical and Biotechnology Industry
• Food & Beverages Industries
• Water & Environment Industries
• Diagnostic Laboratories
• Blood Banks
• Hospitals
• Others

By Region

• North America
• Western Europe
• Eastern Europe
• Latin America
• Asia Pacific
• Japan
• Middle East & Africa

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/6955

Report Highlights:

• Shifting industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size, recent industry trends
• Key competition landscape, market structure, regulatory scenario
• Economical spending, regional healthcare outlook, consumer healthcare expenditure
• Strategies for key players and product offerings, channel strategies, regional foot print, channel footprint
• A neutral perspective towards market performance in terms of value

Chronic Obstructive Pulmonary Disease (COPD) are a group of progressive lung diseases which interfere with the airflow and make it difficult to breathe. The lung disease include non-reversible asthma, emphysema chronic bronchitis. The air flow is narrowed due to the damage of the lung tissues. Air pollution and smoking are the main risk factors of this disease. COPD is a common and incurable disease which is characterized by increased breathlessness, persistent respiratory symptoms and airflow limitations. The biomarkers are obtained in the form of bronchi alveolar fluids sputum, blood, urine and exhaled breath. These compounds are produced by the metabolic process in the body and are non-invasive metabolic markers. These biomarkers provide information to verify the disease, its stage, treatment and responses.Gain complete access to the report @ https://www.futuremarketinsights.com/reports/asthma-and-copd-biomarkers-market

Factor driving the Asthma and COPD Biomarker market

Asthma and COPD biomarker market is primarily driven by the increasing smoking rate and growing pollution levels. According to WHO reports 64 million people had COPD and 3 million people died of COPD in 2004. Long-term exposure to chemical fumes, vapours and dusts are also some factors which are causing COPD and driving the market. Moreover the demand of breath analyzers is increasing in schools hospitals and other institutions to ensure the safety of the individuals.

The COPD biomarkers are non-invasive and are produced by the metabolic process in the body in the form of urine, sputum, and by exhaled breath etc.  Increased levels of FeNO (Fractional exhaled nitric oxide) in exhaled breath is obtained by the hand held breath analyzers. These devices are easy to use and quick in diagnoses of the disease. Fibrinogen as a biomarker is measured in the plasma. Its increased levels provide the severity of COPD, airflow colonization and emphysema. The increased level of fibrinogen, white blood cells and C- reactive protein (CRP) combined together is accounted as a major risk for COPD. However, lack of awareness and diagnosis of chronic obstructive pulmonary diseases is hindering the growth of asthma and COPD biomarker market. Also if the disease is not detected at the earliest stage it could lead to respiratory infections, heart problems, lung cancer and high blood pressure. The overall market of asthma and COPD biomarker is pushed by the increasing demand of growing expenditure on healthcare. Asthma and COPD biomarker market offers the potential to identify disease in its earliest phase and the technology in the devices and the test kits holds a strong perception in future with its continued investment.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6937

Competition Outlook

Some of the major players identified in Asthma and COPD biomarker market are Spirosure inc. GE Healthcare, Astrazeneca, Owlstone Medical Ltd, Circassia Limited, Bedfont® Scientific Ltd., ECO MEDICS AG., Vitalograph, Mologic ltd,  Akers Biosciences, Inc  etc. The Companies are involved in collaboration agreements for R&D in order to exploit maximum potential. Also they are mainly focused to strengthen the core competencies of their product portfolio with the increasing demand for the diagnosis of COPD and asthma.

Small Scale Manufacturers/Providers	Medium Scale Manufacturers/Providers	Large Scale Manufacturers/Providers
Mologic ltd, Akers Biosciences, Inc	Circassia Limited Bedfont® Scientific Ltd Vitalograph ECO MEDICS AG. Spirosure inc.	GE Healthcare Astrazeneca Owlstone Medical Ltd

Research Methodology

The market sizing of Asthma and COPD biomarker market will be done by adoption data triangulation approach. Demand side approach will be followed to assess the actual market size of Asthma and COPD biomarker. Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end use facilities, adoption rate and future impact of new technologies. Additionally, per capita consumption of test and among end users is tracked at a granular level to obtain the most accurate information. Each piece of information is eventually analyzed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side respondents such as physicians, laboratory and diagnostic laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6937

Key data points covered in report

The report covers exhaustive analysis on:

• Asthma and COPD biomarker market by target areas, modality, end user and region
• Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by method type, end user and country segments
• Asthma and COPD biomarker Market Dynamics & Opportunity Assessment
• Historical Actual Market Size, 2013 – 2017
• Asthma and COPD biomarker market Size & Forecast 2018-2028
• Asthma and COPD biomarker Current Trends/Issues/Challenges
• Competition & Companies involved

Market Segmentation 

Market by application

• Chronic Bronchitis
• Emphysema
• Refractory Asthma

Market by Test Type

• Breath Analyzing
• Sputum tests
• Urine tests
• Plasma tests

Market by End user

• Hospitals
• Diagnostic Laboratories
• Asthma Clinics

Market by Region

• North America
• Latin America
• Europe
• Asia Pacific Excluding Japan
• Japan
• Middle East & Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6937

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape, market structure, regulatory scenario
• Epidemiology outlook for diseases
• Economical spending, regional healthcare outlook, consumer healthcare expenditure
• Availability of device, cost of the test, specificity and sensitivity
• Strategies for key players and product offerings, Channel strategies, regional foot print, channel footprint
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance in terms of value and volume

Future Market Insights (FMI), a Leading Market Research and Competitive Intelligence Provider Offers Exhaustive Analysis on Key Factors Burgeoning the Sales in the Global Advanced Wound Management Market over the Assessment Period (2021-2031)

Future Market Insight’s (FMI’s) latest study published on the Advanced Wound Management market provide insights into key factors uplifting the sales over the next ten years. It provides unbiased analysis on key trends, drivers, and opportunities across key segments, the report also provides strategic analysis on the incumbents, existing players, and leading players operating in the Advanced Wound Management market.

As per comprehensive research conducted by ESOMAR-certified consulting firm FMI, the global Advanced Wound Management market is projected to witness robust growth during the forecast year 2021-2031. The report emphasizes on providing key insights into diverse features including demand, product developments, revenue generation, and sales in the Advanced Wound Management market.

The study offers a detailed analysis of dynamics including driver, restraints, opportunities, and challenges, and also highlights their consequent impact on the market.

“To remain ‘ahead’ of your competitors, request for a sample” https://www.futuremarketinsights.com/reports/sample/rep-gb-8422

Advent of Telehealth and Virtual Care to Create Tailwind for the Advanced Wound Management Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth have gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Advanced Wound Management market.

Key Advanced Wound Management Market Takeaways and Projections

The U.S. is estimated to continue dominating the North America market, projecting fastest growth in the region through 2031.
Germany Advanced Wound Management market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2021 and 2031.
China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8422

Report Benefits & Key Questions Answered

Advanced Wound Management Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Advanced Wound Management market. It also studies the impact of these dynamics on the market for the previous assessment period 2016-2020 to forecast the scope of market growth over the coming forecast period 2021-2031.
Advanced Wound Management Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Advanced Wound Management market. As per the survey, Advanced Wound Management sales will project steady growth over the forecast period.

Advanced Wound Management  Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Advanced Wound Management market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
Advanced Wound Management Category & Segment Level Analysis: FMI’s category & segment level analysis provides insights into key factors affecting the market growth across various segments in terms of (segment 1), (segment 2), and (segment 3). It also uncovers critical opportunities across each segment to assist key players to capitalize on the,
Advanced Wound Management Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Advanced Wound Management market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Advanced Wound Management market.

Some of the prominent market players are profiled by FMI
B. Braun Melsungen AG
Mölnlycke Health Care
ConvaTec Group plc
Coloplast A/S, SIGVARIS
Acelity L.P. Inc.
3M
BSN Medical
Ethicon Inc.
Medline Industries, Inc.
Smith & Nephew PLC.

Advanced Wound Management Demand Analysis by Category
By Product Type:

Advanced wound dressings
Alginates
Collagens
Films
Foams
Hydrocolloids
Hydrofibers
Hydrogels
Wound contact layers
Superabsorbent dressings
Negative pressure wound therapy devices
Standalone NPWT devices
Portable NPWT devices
Single-use disposable NPWT devices
NPWT accessories

By Application Type:

Chronic ulcers
Venous leg ulcers
Diabetic foot ulcers
Pressure ulcers
Non-healing surgical wounds
Traumatic wounds
Burn cases

By End-User Type:

Hospitals
Clinics
Ambulatory surgical centers
Skilled nursing facilities

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8422

Region

North America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

[236 Pages Report]  The global Meningococcal Vaccines Market is forecast to surpass US$ 3.66 Bn in 2022. With rising prevalence of meningococcal disease worldwide, the overall sales of meningococcal vaccines are slated to rise at a healthy CAGR of 8.6% between 2022 and 2028, reaching a total of around US$ 6 Bn by 2028.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1252

Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives.

The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need.

The governments of several countries across the globe initiate immunisation programmes periodically and these programmes are backed by global organisations such as UNICEF and WHO and private not for profits like the Global Alliance for Vaccines and Immunization (GAVI).

A classic example of how private-public partnerships are helping boost vaccination programmes across deep regional pockets is Brazil.

In 2010, Ezequiel Dias Foundation, Brazil formed a strategic alliance with Novartis Vaccines & Diagnostics for the sustainable supply of Menjugate MenC vaccines for Brazil’s National Immunization Program. By 2015, Brazil became self-sufficient in the production of the meningococcal C conjugated vaccine for the country’s public vaccination programmes. Such initiatives at the global level are anticipated to support global immunisation goals and at the same time boost growth of the meningococcal vaccines market.

Factors Leading to Worldwide Adoption of Meningococcal Vaccination Programmes

The global meningococcal vaccines market is expected to be driven by enhanced access to vaccines in low and middle-income countries, growing investments by manufacturers and governments to cope with pandemic meningitis outbreaks, and rapidly growing consumption of meningococcal vaccines bolstered by immunisation alliances and mass vaccination campaigns among others.

Partnerships and alliances between manufacturers and governmental healthcare organisations are facilitating the speedy introduction of vaccines in some of the economically challenged countries of the Middle East and Africa region. Enhanced access to vaccines in under-penetrated global markets is expected to accelerate revenue growth of the global meningococcal vaccines market.

Approval of new vaccines in the U.S and Europe in 2015 and 2017 to treat meningococcal meningitis has revolutionised the global immunisation landscape. This is further boosting the growth trajectory of the global market for meningococcal vaccines.

GlaxoSmithKline to Lead the Global Meningococcal Vaccines Market with About 50% Market Share Recorded in 2017

The global meningococcal vaccines market is highly consolidated, with GlaxoSmithKline and Sanofi together holding about 80% of the global market share in 2017. Pfizer is the third largest company in this market with just under 12% market share in 2017.

Companies are expanding their production capacities through the acquisition of established vaccines production units of other global or local companies.

Sanofi has a huge pipeline of 17 active meningococcal vaccines programmes and is targeting emerging markets; while GlaxoSmithKline has 5 active pipeline programmes for meningococcal vaccines, all of which are in the phase II clinical stage. Addition of the vaccine Bexsero has enabled GlaxoSmithKline to defend its brand against Sanofi’s aggressive portfolio in the paediatric vaccines space.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1252

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Digitization in the healthcare sector has revamped the ultrasound systems market. The advancements in different spheres of the industry has benefited not just the patients but the market too, as the demand for medical examination has surged over the past decade. A new market research report by Future Market Insights, revolves around an in-depth and an all-inclusive analysis of Global Ultrasound Systems Market, reveals a strong growth of the market due to upgraded services provided to the patients and also the easier approach to the internal body examination witnessed with the usage of ultrasound systems. According to the outcomes of global forecast mentioned in the report titled ‘Ultrasound Systems Market – Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028’, the global ultrasound systems market is expected to reach a market value of over US$ 12,500 Mn by the end of 2028, growing at an impressive CAGR of 5.7% during the forecast period.

The global cancer tissue diagnostics industry is hugely driven by sheer number of biomarkers used for early cancer detection from blood or plasma, while prevalence of lung, breast and prostate cancers has been another constant driving factor to the demand growth. Despite getting battered by the outbreak of the COVID-19, the industry players are coming back to track with the increase in investment in research & development (R&D) activities and focus on launching wider variety of products.

In single-dose radiotherapy, a single dose of radiation is delivered directly to the tumor in a few minutes and is said to be a safe and effective method for treating men having low-risk prostate cancer. According to Future Market Insights (FMI), the demand for single-dose therapy is expected to rise considerably, enabling the market to surpass US$ 1.1 Bn by 2021. In the coming years the rising cases of breast cancer will support the expansion of the market.